Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior (FARMS-2)
Sponsor: University of Illinois at Urbana-Champaign
Listed as NCT01956227, this PHASE1/PHASE2 trial focuses on Adult Disease and Multiple Sclerosis and remains completed. Sponsored by University of Illinois at Urbana-Champaign, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Illinois at Urbana-Champaign
For direct contact, visit the study record on ClinicalTrials.gov .